#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-renal cell carcinoma of kidney Monogenic diabetes Medulloblastoma Primary myelofibrosis Glomerulonephritis minimal lesion Small cell lung cancer recurrent Angiosarcoma metastatic Hypergammaglobulinaemia benign monoclonal Post transplant lymphoproliferative disorder Dementia Anal cancer recurrent Alternating hemiplegia of childhood B-cell small lymphocytic lymphoma refractory Mucopolysaccharidosis III Parkinson's disease More trials…

    Learn about Rare Diseases

    Lymphangioma – Basic Information VEXAS syndrome Medulloblastoma recurrent – Treatment Primary biliary cholangitis – Treatment Hereditary angioedema – Life with Disease Burkitt’s lymphoma – Life with Disease Breast angiosarcoma Atypical teratoid/rhabdoid tumour of CNS – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5733584 Sar442970 Atl001 Hydrocortisone Diacerein Incb000928 HLX43 Oritavancin IMB 101 Retifanlimab Rbd1016 Pioglitazone Entrectinib Ibutamoren Mesilate Sotrovimab Ion440 Amcenestrant Bupivacaine SOFTISAN 378 Clopidogrel Hydrogen Sulfate More therapies…

    Learn about Your Condition

    Ankylosing spondylitis Infertility female Becker's muscular dystrophy Respiratory distress Psychotic behaviour Inflammation Meniere's disease Pertussis Chordoma Guttate psoriasis Leiomyosarcoma recurrent Hereditary angioedema Pelizaeus-Merzbacher disease Primary myelofibrosis Anal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neuroendocrine carcinoma of the skin

  • A Study of Cemiplimab Given Before Surgery in Patients with Early Stage Merkel Cell Carcinoma of the Skin

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma of the skin
    Investigated Drugs:
    • Cemiplimab
    Germany

  • Study of Retifanlimab Combined with Carboplatin, Cisplatin and Etoposide Before Surgery in Patients with Resectable Merkel Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma of the skin
    Investigated Drugs:
    • Retifanlimab
    • Carboplatin
    • Cisplatin
    Italy

  • Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Neuroendocrine carcinoma of the skin
    • Non-small cell lung cancer
    Investigated Drugs:
    • Bt-001
    • Human Vaccinia Immunoglobulin
    • Pembrolizumab
    Belgium France

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Malignant melanoma
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Cemiplimab
    • Avelumab
    • Atezolizumab
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!